Design Therapeutics's total assets for Q2 2025 were $222.89M, a decrease of -6.14% from the previous quarter. DSGN total liabilities were $9.85M for the fiscal quarter, a 3.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.